Ornithine decarboxylase, kidney size, and the tubular hypothesis of glomerular hyperfiltration in experimental diabetes
- PMID: 11160138
- PMCID: PMC199175
- DOI: 10.1172/JCI10963
Ornithine decarboxylase, kidney size, and the tubular hypothesis of glomerular hyperfiltration in experimental diabetes
Abstract
In early diabetes, the kidney grows and the glomerular filtration rate (GFR) increases. This growth is linked to ornithine decarboxylase (ODC). The study of hyperfiltration has focused on microvascular abnormalities, but hyperfiltration may actually result from a prior increase in capacity for proximal reabsorption which reduces the signal for tubuloglomerular feedback (TGF). Experiments were performed in Wistar rats after 1 week of streptozotocin diabetes. Kidney weight, ODC activity, and GFR were correlated in diabetic and control rats given difluoromethylornithine (DFMO; Marion Merrell Dow, Cincinnati, Ohio, USA) to inhibit ODC. We assessed proximal reabsorption by micropuncture, using TGF as a tool for manipulating single-nephron GFR (SNGFR), then plotting proximal reabsorption versus SNGFR. ODC activity was elevated 15-fold in diabetic kidneys and normalized by DFMO, which also attenuated hyperfiltration and hypertrophy. Micropuncture data revealed an overall increase in proximal reabsorption in diabetic rats too great to be accounted for by glomerulotubular balance. DFMO prevented the overall increase in proximal reabsorption. These data confirm that ODC is required for the full effect of diabetes on kidney size and proximal reabsorption in early streptozotocin diabetes and are consistent with the hypothesis that diabetic hyperfiltration results from normal physiologic actions of TGF operating in a larger kidney, independent of any primary malfunction of the glomerular microvasculature.
Figures
Comment on
-
Hypertrophy and hyperfunction of the diabetic kidney.J Clin Invest. 2001 Jan;107(2):161-2. doi: 10.1172/JCI12066. J Clin Invest. 2001. PMID: 11160131 Free PMC article. No abstract available.
Similar articles
-
Ornithine decarboxylase inhibitor eliminates hyperresponsiveness of the early diabetic proximal tubule to dietary salt.Am J Physiol Renal Physiol. 2008 Oct;295(4):F995-F1002. doi: 10.1152/ajprenal.00491.2007. Epub 2008 Jun 18. Am J Physiol Renal Physiol. 2008. PMID: 18562630 Free PMC article.
-
Inhibition of renal ornithine decarboxylase activity prevents kidney hypertrophy in experimental diabetes.Am J Physiol. 1993 Feb;264(2 Pt 1):C453-6. doi: 10.1152/ajpcell.1993.264.2.C453. Am J Physiol. 1993. PMID: 8447376
-
Inhibition of renal ornithine decarboxylase activity fails to reduce kidney size and urinary albumin excretion in diabetic rats with manifest kidney hypertrophy.Mol Cell Endocrinol. 1995 Jan;107(1):123-8. doi: 10.1016/0303-7207(94)03433-t. Mol Cell Endocrinol. 1995. PMID: 7796931
-
Sodium/glucose cotransporter 2 inhibitors and prevention of diabetic nephropathy: targeting the renal tubule in diabetes.Am J Kidney Dis. 2014 Jul;64(1):16-24. doi: 10.1053/j.ajkd.2014.02.010. Epub 2014 Mar 25. Am J Kidney Dis. 2014. PMID: 24673844 Review.
-
Glomerular hemodynamic and structural alterations in experimental diabetes mellitus.FASEB J. 1988 May;2(8):2339-47. doi: 10.1096/fasebj.2.8.3282959. FASEB J. 1988. PMID: 3282959 Review.
Cited by
-
Large kidneys predict poor renal outcome in subjects with diabetes and chronic kidney disease.BMC Nephrol. 2010 Mar 3;11:3. doi: 10.1186/1471-2369-11-3. BMC Nephrol. 2010. PMID: 20199663 Free PMC article.
-
Modifying chronic kidney disease progression with the mineralocorticoid receptor antagonist finerenone in patients with type 2 diabetes.Diabetes Obes Metab. 2022 Jul;24(7):1197-1205. doi: 10.1111/dom.14696. Epub 2022 Apr 18. Diabetes Obes Metab. 2022. PMID: 35302284 Free PMC article. Review.
-
Activation of the succinate receptor GPR91 in macula densa cells causes renin release.J Am Soc Nephrol. 2009 May;20(5):1002-11. doi: 10.1681/ASN.2008070740. Epub 2009 Apr 23. J Am Soc Nephrol. 2009. PMID: 19389848 Free PMC article.
-
Biochemical parameters of renal impairment/injury and surrogate markers of nephron number in intrauterine growth-restricted and preterm neonates at 30-40 days of postnatal corrected age.Pediatr Nephrol. 2016 Dec;31(12):2277-2287. doi: 10.1007/s00467-016-3484-4. Epub 2016 Aug 25. Pediatr Nephrol. 2016. PMID: 27557556
-
Inflammation primes the murine kidney for recovery by activating AZIN1 adenosine-to-inosine editing.J Clin Invest. 2024 Sep 3;134(17):e180117. doi: 10.1172/JCI180117. J Clin Invest. 2024. PMID: 38954486 Free PMC article.
References
-
- O’Bryan GT, Hostetter TH. The renal hemodynamic basis of diabetic nephropathy. Semin Nephrol. 1997;17:93–100. - PubMed
-
- Parving, H.H., Osterby, R., and Ritz, E. 2000. Diabetic nephropathy. In The kidney. 6th edition. B. Brenner, editor. WB Saunders Co. Philadelphia, Pennsylvania, USA. 1731–1773.
-
- Daniels FH, Arendshorst WJ. Tubuloglomerular feedback kinetics in spontaneously hypertensive and Wistar-Kyoto rats. Am J Physiol. 1990;259:F529–F534. - PubMed
-
- Mogensen CE, Andersen MJF. Increased kidney size and glomerular filtration rate in early juvenile diabetes. Diabetes. 1973;22:706–712. - PubMed
-
- Ross J, Goldman JK. Effect of streptozotocin-induced diabetes on kidney weight and compensatory hypertrophy in the rat. Endocrinology. 1971;88:1079–1083. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
